The fourth quarter reflected the strengths and challenges facing Portillo's Inc. in 2025. While our core markets continue to ...

Annual R&D Expenses -- $41.1 million in 2025, a 19% decrease driven primarily by a $4.5 million reduction in lab and ...

Claude Cowork lets AI analyze files, browse the web, and run business tasks autonomously. Allie K. Miller explains exactly ...

Q4 2025 Earnings Call February 24, 2026 10:00 AM ESTCompany ParticipantsChris BrandonMichael Miles - Chairman of the Board ...

In RNA-seq library preparation, selecting the appropriate number of PCR cycles is a critical balancing act to avoid overcycling.

Cronos Group Inc. (NASDAQ:CRON) Q4 2025 Earnings Call Transcript February 26, 2026 Cronos Group Inc. beats earnings ...

FDA Approval for Pediatric Indication -- LINZESS received U.S. FDA approval in November 2025 for IBS-C patients aged 7-17, ...

Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

Operator: Good afternoon, ladies and gentlemen, and welcome to the Innodata to Report Fourth Quarter and Fiscal Year 2025 Results Conference Call.

How Lauren Boebert and Benny Johnson ruined James Comer’s big shot ...

In an interview with dvm360 at VMX, Hoyer discussed a recommended strategy for identifying interpreting intramural ...